Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 12 | 2022 | 3445 | 1.440 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2019 | 194 | 1.160 |
Why?
|
| Unfolded Protein Response | 3 | 2022 | 233 | 1.030 |
Why?
|
| Inflammasomes | 4 | 2019 | 496 | 1.010 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2022 | 116 | 0.780 |
Why?
|
| RNA, Double-Stranded | 1 | 2022 | 290 | 0.770 |
Why?
|
| Phosphatidylinositols | 1 | 2020 | 291 | 0.700 |
Why?
|
| Interleukin-1beta | 3 | 2019 | 973 | 0.650 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2019 | 190 | 0.620 |
Why?
|
| Endoribonucleases | 4 | 2022 | 229 | 0.580 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 756 | 0.550 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 1900 | 0.550 |
Why?
|
| Endoplasmic Reticulum | 4 | 2019 | 1146 | 0.520 |
Why?
|
| Macrophages | 8 | 2020 | 5651 | 0.460 |
Why?
|
| Membrane Proteins | 2 | 2022 | 7880 | 0.430 |
Why?
|
| Mitochondria | 2 | 2022 | 3513 | 0.400 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1403 | 0.390 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 718 | 0.390 |
Why?
|
| Dietary Fats | 1 | 2019 | 2016 | 0.380 |
Why?
|
| Inositol | 2 | 2022 | 218 | 0.380 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2011 | 300 | 0.350 |
Why?
|
| Chlamydophila pneumoniae | 2 | 2018 | 55 | 0.320 |
Why?
|
| Mammals | 2 | 2023 | 1143 | 0.300 |
Why?
|
| Lipid Metabolism | 2 | 2018 | 1885 | 0.280 |
Why?
|
| MicroRNAs | 1 | 2022 | 3750 | 0.270 |
Why?
|
| Ribonucleases | 2 | 2022 | 284 | 0.250 |
Why?
|
| Aldehyde-Lyases | 1 | 2022 | 14 | 0.220 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2003 | 272 | 0.210 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2022 | 55 | 0.210 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 658 | 0.200 |
Why?
|
| Muscle Development | 1 | 2003 | 272 | 0.200 |
Why?
|
| Mice | 13 | 2022 | 81154 | 0.200 |
Why?
|
| Receptors, LDL | 2 | 2016 | 477 | 0.200 |
Why?
|
| Phosphorylation | 3 | 2022 | 8436 | 0.200 |
Why?
|
| Animals | 19 | 2023 | 168660 | 0.190 |
Why?
|
| Electron Transport Complex I | 1 | 2022 | 140 | 0.190 |
Why?
|
| Apolipoproteins E | 2 | 2017 | 1436 | 0.190 |
Why?
|
| Cells, Cultured | 6 | 2019 | 19232 | 0.190 |
Why?
|
| S-Adenosylmethionine | 1 | 2021 | 212 | 0.180 |
Why?
|
| Protein Kinases | 2 | 2005 | 1640 | 0.180 |
Why?
|
| Ribonucleoproteins | 1 | 2021 | 380 | 0.170 |
Why?
|
| Signal Transduction | 9 | 2022 | 23398 | 0.170 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1888 | 0.160 |
Why?
|
| Oligonucleotides | 1 | 2021 | 572 | 0.160 |
Why?
|
| Chlamydophila Infections | 1 | 2018 | 23 | 0.160 |
Why?
|
| Vasculitis | 1 | 2022 | 519 | 0.150 |
Why?
|
| Amino Acids | 1 | 2003 | 1733 | 0.150 |
Why?
|
| Autoantigens | 1 | 2021 | 892 | 0.150 |
Why?
|
| Lipids | 3 | 2018 | 3307 | 0.150 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2022 | 546 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2016 | 77 | 0.140 |
Why?
|
| Inflammation | 3 | 2016 | 10629 | 0.140 |
Why?
|
| Intracellular Membranes | 1 | 2016 | 391 | 0.130 |
Why?
|
| Interleukin-18 | 1 | 2017 | 249 | 0.130 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3082 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2021 | 14563 | 0.120 |
Why?
|
| Homeostasis | 2 | 2017 | 3337 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2005 | 4925 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2018 | 1518 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 12066 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3645 | 0.090 |
Why?
|
| Apoptosis | 2 | 2016 | 9718 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2016 | 743 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2022 | 21824 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7719 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2023 | 4286 | 0.090 |
Why?
|
| Cholesterol | 1 | 2018 | 2922 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2509 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2062 | 0.080 |
Why?
|
| PPAR gamma | 1 | 2011 | 492 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2018 | 2961 | 0.070 |
Why?
|
| Cell Enlargement | 1 | 2005 | 61 | 0.070 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 56 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2021 | 2110 | 0.070 |
Why?
|
| Myoblasts | 1 | 2003 | 238 | 0.050 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2021 | 17 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2504 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7324 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2021 | 191 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2007 | 1211 | 0.050 |
Why?
|
| Adipocytes | 1 | 2007 | 1182 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2008 | 1608 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13273 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2021 | 360 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3706 | 0.040 |
Why?
|
| Foam Cells | 1 | 2018 | 71 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2021 | 13028 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2018 | 224 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 2017 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2899 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 743811 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 1344 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2016 | 33 | 0.040 |
Why?
|
| Sirolimus | 1 | 2003 | 1565 | 0.030 |
Why?
|
| bcl-Associated Death Protein | 1 | 2016 | 107 | 0.030 |
Why?
|
| Phylogeny | 1 | 2023 | 2796 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18027 | 0.030 |
Why?
|
| Genome | 1 | 2023 | 1806 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 2123 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2938 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3863 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 2119 | 0.030 |
Why?
|
| Male | 4 | 2019 | 349776 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4552 | 0.020 |
Why?
|
| Receptors, CCR2 | 1 | 2011 | 212 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 1142 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5216 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2217 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 1151 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 5752 | 0.020 |
Why?
|
| Asthma | 1 | 2007 | 6010 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3639 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 2764 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4251 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10477 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 5881 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16674 | 0.020 |
Why?
|
| Obesity | 1 | 2007 | 12744 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11360 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5532 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16361 | 0.010 |
Why?
|
| Mutation | 1 | 2021 | 29777 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17439 | 0.010 |
Why?
|
| Female | 3 | 2018 | 380020 | 0.010 |
Why?
|
| Adult | 1 | 2023 | 213889 | 0.010 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_